Johnson & Johnson rolls out one-shot vaccine
Johnson and Johnson's coronavirus vaccine is being shipped across the U.S., adding a third vaccine to the country's arsenal. Errol Barnett reports.
Vaccine
As COVID vaccinations rise, testing declines
As COVID-19 vaccinations rise across the country, testing appears to be declining as variants spread. "CBS This Morning" lead national correspondent David Begnaud spoke to a hair stylist who depends on regular testing to keep her job. She says her usual testing site closed down.
Johnson & Johnson CEO on vaccine authorization
Johnson and Johnson CEO Alex Gorsky joins "CBS This Morning" to discuss FDA emergency use authorization of his company's one-shot coronavirus vaccine, a first.
Johnson & Johnson ships COVID-19 vaccine
Johnson & Johnson has begun shipping its single-dose COVID-19 vaccine, the third jab to become available in the United States as the country races to get Americans inoculated. Dr. Rick Nettles, the vice president of medical affairs for Janssen Infectious Diseases and Vaccines at Johnson & Johnson, joins CBSN to answer questions about the company's vaccine.
Johnson & Johnson begins shipping vaccine
The new single-dose vaccine began shipping out Monday morning after the FDA issued emergency use authorization for the shot. It is the third COVID-19 vaccine to become available in the United States. CBS News' Debra Alfarone joins CBSN AM to discuss.
What to expect from Johnson & Johnson vaccine
The new Johnson & Johnson vaccine could roll out as early as this week. CBS News medical contributor Dr. David Agus has more on what to expect.
U.S. hits grim COVID milestone amid new hope of third vaccine
CBS News senior national correspondent Mark Strassmann reports on the latest developments in vaccine distribution as the U.S. continues its battle against COVID-19.
Is the one-shot method better than the two-shot method?
Which vaccine is the most effective against the coronavirus? The Moderna and Pfizer vaccines require two shots to be fully vaccinated. However, the new Johnson and Johnson vaccine uses a one-shot method and is easier to store. CBS News researcher Max Bayer joins CBSN's Land Zak to discuss the difference between the vaccines, their efficacy against variants, and if pregnant women should be vaccinated.
FDA approves one-shot vaccine
On Saturday, the FDA approved the one-shot Johnson & Johnson COVID-19 vaccine. The race to vaccinate is picking up as new variants have been identified. Danya Bacchus reports.
FDA panel OKs Johnson & Johnson COVID-19 vaccine
An FDA advisory panel voted Friday in favor of Johnson & Johnson's coronavirus vaccine. If the FDA gives the final approval, millions of doses could ship out as early as this weekend. The news comes as the CDC warns declines in cases and hospitalizations may be stalling. Dr. Dara Kass, and ER doctor and medical contributor for Yahoo News, joins CBSN to discuss the latest in the fight against COVID-19.
Some miss second dose of COVID vaccine
A new report by CBS MoneyWatch found an increasing number of people are not getting their second COVID-19 vaccine shot when they're supposed to. CBSN's Tanya Rivera spoke with MoneyWatch senior report Stephen Gandel about what this means for the nation's vaccination efforts.
Queen Elizabeth encourages COVID vaccinations
Britain's Queen Elizabeth is encouraging people to get vaccinated against the coronavirus to help protect others. She took part in a Zoom conference with doctors and said the shot "didn't hurt at all." CBS News' Ian Lee reports from London.
Study: Pfizer vaccine reduces transmission
A new U.K. study found the Pfizer coronavirus vaccine reduced transmission after just one dose. Dr. Bob Lahita joins CBSN to discuss the findings, as well as the possible need for booster shots against new variants, a new CBS News poll on attitudes about vaccination, and the process of reopening schools amid the pandemic.
"A Shot of Hope": Getting the vaccine
Millions of Americans have received doses of the coronavirus vaccines so far. On Thursday, President Biden marked 50 million shots given since he took office. This is a significant milestone, but access remains an issue. Acting FEMA director Bob Fenton explains how his agency is trying to ramp up the rollout of the vaccine. Plus, Dr. Anthony Fauci explains if the new Johnson & Johnson vaccine will be effective against a new variant found in New York City.
50 million COVID shots administered since Biden inauguration
The Biden administration is marking a new milestone in the fight against the coronavirus pandemic. The U.S. has administered 50 million of its promised 100 million vaccine doses in just five weeks. This comes as homegrown variants cause alarm on both coasts on the country. Dr. Richard Besser, the president and CEO of the Robert Wood Johnson Foundation and the former acting director of the CDC, joins CBSN to discuss the latest.
Vaccine maker races to combat new variant
AstraZeneca will try for emergency approval of its vaccine in the U.S. after scientists found this version of the vaccine has been effective against the U.K. variant. Charlie D'Agata reports.
Fighting the COVID-19 variants
Moderna is seeking approval for an updated vaccine aimed at fighting the COVID-19 variant first found in South Africa. It means people who are vaccinated twice might need a third shot, and possibly more in the future. David Begnaud reports.
Third COVID vaccine nears U.S. authorization
The FDA has deemed the Johnson & Johnson single-shot coronavirus vaccine to be safe and effective, paving the way for an emergency use authorization. Dr. Ashish Jha, the dean of Brown University's School of Public Health, joins "CBS This Morning" to explain how Johnson & Johnson stacks up against Moderna and Pfizer, and whether the virus variant first found in South Africa complicates vaccination.
Johnson & Johnsons COVID vaccine declared safe
The FDA confirms the Johnson & Johnson coronavirus vaccine is safe and effective. The single-dose vaccine could receive emergency approval as early as Friday. If authorized, the Biden administration could ship up to 4 million doses by next week. CBS News' Nikki Battiste reports on the latest information, then infectious disease specialist Dr. Uzma Syed joins CBSN with analysis.
Johnson & Johnson vaccine deemed safe and effective
The FDA found Johnson & Johnson's one-dose coronavirus vaccine to be safe and effective, though slightly less effective than the Modern and Pfizer vaccines, which require two doses. Nikki Battiste reports.
FDA: Johnson & Johnson vaccine works well
An FDA review released today confirms the single-dose Johnson & Johnson vaccine is both safe and effective against COVID-19, likely setting the stage for a third vaccine to be authorized for use in the U.S. Dr. Neeta Ogden joins CBSN with more.
Some Biden nominees face challenges
Several Biden Cabinet nominees are facing confirmation hearings today as the president holds a virtual bilateral meeting with Canadian Prime Minister Justin Trudeau. CBS News senior White House correspondent Weijia Jiang joined CBSN with the latest.
Grocery union demands vaccines and hazard pay
Grocery workers have fought for hazard pay and expressed concerns for their safety for since the beginning of the COVID-19 pandemic nearly a year ago. Marc Perrone, president of the United Food and Commercial Workers International Union, spoke with Anne-Marie Green and Vladimir Duthiers about what would help grocery workers and Kroger's plans to close stores in California and Washington state after local governments required them to give workers hazard pay.
Vaccine out of reach for many Black Americans
In Baltimore, Maryland, Black Americans make up more than 60% of the population, but just 5.4% of Black residents have gotten the COVID-19 vaccine. Now, church and community leaders are pushing for new ways to bring more shots and better information to the city's Black population. Jericka Duncan reports.
Gottlieb: Americans "should be confident" in Johnson & Johnson vaccine
Dr. Scott Gottlieb, the former FDA commissioner, says the Johnson & Johnson single-dose shot is a "good vaccine."
Exclusive
U.S. may have withheld warnings to Ukraine on deadly Kyiv strikes
Pope's cancer prognosis may depend on these factors, doctors say
Exclusive
Top meme coin buyers vying for Trump dinner appear to be overseas
Inflation surged in September as U.S. energy costs jumped
Live
Houthis launch new attack on Saudi capital as Trump mulls strikes
World's oldest shipwreck found off Turkey's coast, archaeologists say
DOJ tells California to review whether noncitizens got mail ballots
Iran and Russia blamed for growing list of hybrid attacks on Europe
